Citigroup
ONCO icon

Citigroup’s Onconetix ONCO Stock Holding History

Citigroup’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.56K Buy
+172
New +$8.96K ﹤0.01% 5394
2022
Q2 		– Hold
0
– -$135K – 6535
2022
Q1 		– Hold
0
– – – 4279

Other funds holding ONCO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Citigroup's ONCO Position: Q1 2026 in Review

Citigroup opened a new position in Onconetix (ONCO) in Q1 2026: 172 shares worth $2.56K. The stake represents ﹤0.01% of the portfolio and ranks #5394 among its holdings.

5 funds tracked by Wall St. Rank hold ONCO as of Q1 2026.

  • Citigroup held 172 shares of Onconetix worth $2.56K as of Q1 2026.
  • Onconetix was a new Citigroup position in Q1 2026.
  • Onconetix made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5394 holding.
  • 5 funds tracked by Wall St. Rank held Onconetix as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.